• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药物及其副作用对精神分裂症患者生活质量的影响。

Impact of antipsychotic agents and their side effects on the quality of life in schizophrenia.

机构信息

Sha'ar Menashe Mental Health Center, Mobile Post Hefer 38814, Israel.

出版信息

Expert Rev Pharmacoecon Outcomes Res. 2002 Aug;2(4):347-56. doi: 10.1586/14737167.2.4.347.

DOI:10.1586/14737167.2.4.347
PMID:19807441
Abstract

Schizophrenia is the most chronic and disabling of mental illnesses and it imposes a disproportionately large economic burden on society. In addition to symptom reduction and cost-effectiveness, quality of life is becoming a critical outcome measure for the efficacy of antipsychotic agents in the treatment of schizophrenia patients. This review concentrates on the influences of antipsychotic agents and their side effects on quality of life of schizophrenia patients. Of the 182 papers elicited in a comprehensive Medline search from 1996-2002, we found only 21 significant papers (11.5%) reporting findings concerning the effect of antipsychotic agents on quality of life of schizophrenia patients. Very few studies directly examined the impact of side effects on quality of life ratings of schizophrenia patients. To date, there is no clear evidence that in the long-term, atypical antipsychotics are more effective or are better tolerated than typical antipsychotics. This review suggests that side effects of antipsychotic agents influence subjective quality of life of schizophrenia patients significantly less than clinical and psychosocial factors. The patient's subjective response to side effects of medication is more predictive of quality of life than the number of those effects. We discuss both patients' and clinicians' perceptions of side effects and quality of life, which should be considered in the evaluation of the efficacy of antipsychotic agents.

摘要

精神分裂症是最慢性和致残的精神疾病之一,它给社会带来了不成比例的巨大经济负担。除了减少症状和成本效益外,生活质量正在成为评估抗精神病药物治疗精神分裂症患者疗效的关键指标。这篇综述集中讨论了抗精神病药物及其副作用对精神分裂症患者生活质量的影响。在对 1996 年至 2002 年进行的全面 Medline 搜索中,我们共找到了 182 篇论文,其中只有 21 篇(11.5%)重要论文报告了抗精神病药物对精神分裂症患者生活质量的影响。很少有研究直接考察副作用对精神分裂症患者生活质量评分的影响。迄今为止,尚无明确证据表明,在长期治疗中,非典型抗精神病药物比典型抗精神病药物更有效或更耐受。这篇综述表明,抗精神病药物的副作用对精神分裂症患者的主观生活质量的影响明显小于临床和社会心理因素。患者对药物副作用的主观反应比副作用的数量更能预测生活质量。我们讨论了患者和临床医生对副作用和生活质量的看法,这应该在评估抗精神病药物的疗效时加以考虑。

相似文献

1
Impact of antipsychotic agents and their side effects on the quality of life in schizophrenia.抗精神病药物及其副作用对精神分裂症患者生活质量的影响。
Expert Rev Pharmacoecon Outcomes Res. 2002 Aug;2(4):347-56. doi: 10.1586/14737167.2.4.347.
2
Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.非典型与典型抗精神病药物治疗精神分裂症在常规护理中的有效性及成本
J Ment Health Policy Econ. 2008 Jun;11(2):89-97.
3
Subjective well-being and quality of life under atypical antipsychotic treatment.非典型抗精神病药物治疗下的主观幸福感和生活质量
Psychopharmacology (Berl). 2002 Jun;162(1):3-10. doi: 10.1007/s00213-002-1052-z. Epub 2002 Apr 20.
4
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).第二代与第一代抗精神病药物对精神分裂症患者生活质量影响的随机对照试验:精神分裂症最新抗精神病药物的成本效用研究(CUtLASS 1)
Arch Gen Psychiatry. 2006 Oct;63(10):1079-87. doi: 10.1001/archpsyc.63.10.1079.
5
The relationship between patient satisfaction and treatment outcomes in schizophrenia.精神分裂症患者满意度与治疗结果之间的关系。
J Psychopharmacol. 2006 Nov;20(6 Suppl):38-56. doi: 10.1177/1359786806071246.
6
Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.抗精神病药物的副作用与精神分裂症患者的健康相关生活质量
Acta Psychiatr Scand Suppl. 2009(438):22-8. doi: 10.1111/j.1600-0447.2008.01310.x.
7
Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.非典型抗精神病药物治疗精神分裂症及相关精神病患者的长期疗效证据综述。
J Psychopharmacol. 2006 Nov;20(6 Suppl):20-37. doi: 10.1177/1359786806071243.
8
Outcome in schizophrenia: beyond symptom reduction.精神分裂症的预后:超越症状缓解
J Clin Psychiatry. 1999;60 Suppl 3:3-7; discussion 8.
9
[Quality of life of patient with schizophrenia treated by conventional and atypical neuroleptics].[使用传统和非典型抗精神病药物治疗的精神分裂症患者的生活质量]
Tunis Med. 2009 Sep;87(9):593-8.
10
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.抗精神病药物联合治疗的利弊:2008年3月于法国尼斯召开的欧洲神经精神药理学会(ECNP)共识会议
Eur Neuropsychopharmacol. 2009 Jul;19(7):520-32. doi: 10.1016/j.euroneuro.2009.04.003. Epub 2009 May 2.

引用本文的文献

1
Validity and reliability of the Chinese version of the Short Form of Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-SF).《简易版生活满意度量表(Q-LES-Q-SF)中文版的有效性和信度》。
Qual Life Res. 2014 Apr;23(3):907-16. doi: 10.1007/s11136-013-0528-0. Epub 2013 Sep 24.
2
The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia.新型非典型抗精神病药物对精神分裂症患者报告结局的影响。
CNS Drugs. 2013 Aug;27(8):625-36. doi: 10.1007/s40263-013-0070-1.
3
Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorders: I. Predictive value of disorder-related factors.
精神分裂症和分裂情感性障碍患者的十年生活质量结局:I. 疾病相关因素的预测价值。
Qual Life Res. 2012 Jun;21(5):837-47. doi: 10.1007/s11136-011-9988-2. Epub 2011 Sep 13.
4
Determinants of changes in perceived quality of life in the course of schizophrenia.精神分裂症病程中生活质量感知变化的决定因素。
Qual Life Res. 2006 Apr;15(3):515-26. doi: 10.1007/s11136-005-2808-9.
5
Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients.简化版生活享受与满意度问卷(Q-LES-Q-18)在精神分裂症、分裂情感性障碍和心境障碍患者中的效度。
Qual Life Res. 2005 Sep;14(7):1693-703. doi: 10.1007/s11136-005-2816-9.
6
Impact of atypical antipsychotics on quality of life in patients with schizophrenia.非典型抗精神病药物对精神分裂症患者生活质量的影响。
CNS Drugs. 2004;18(13):877-93. doi: 10.2165/00023210-200418130-00004.